ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 017,12
0,75%
Dow Jones
38 675,68
1,18%
DAX
18 161,02
0,93%
Brent Oil
83,565
0,53%
Bitcoin
64 161,20
0,25%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. VolitionRX Limited (VNRX)

  7. VolitionRX Limited (VNRX) Actualités

VNRX VolitionRX Limited

0,8909
0,00 (0,00%)
Avant marché
Dernière mise à jour : 10:03:32
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
VolitionRX Limited VNRX AMEX Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 0,8909 10:03:32
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,8909
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
23/4/202414:00PRNUSNu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe..
26/3/202412:21IHMARKETNEWSU.S. Index Futures on the Rise, Oil Prices Show Stability
25/3/202421:10PRNUSVolitionRx Limited Announces Full Fiscal Year 2023 Financial..
21/3/202413:30PRNUSVolitionRx Limited Schedules Fourth Quarter and Full Year..
20/3/202413:30PRNUSVolition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer..
19/3/202421:30PRNUSVolition appoints Dr Andrew Retter as Chief Medical Officer
14/2/202422:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202421:56EDGAR2Form SC 13D/A - General statement of acquisition of..
02/2/202414:00PRNUSVolition to Share Nu.Q® NETs Strategy Update at Upcoming..
26/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202414:00PRNUSVolition Issues Business Review 2023
03/1/202416:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202414:00EDGAR2Form 8-K - Current report
20/12/202316:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202316:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202315:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202315:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202314:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202314:07EDGAR2Form 8-K - Current report
05/12/202314:00PRNUSVolitionRx Secures Approximately $5.5 Million in Belgium..
28/11/202315:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202315:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202316:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/11/202317:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202322:10PRNUSVolitionRx Limited Announces Third Quarter 2023 Financial..
08/11/202314:00PRNUSVolitionRx Limited Schedules Third Quarter 2023 Earnings..
06/11/202312:24PRNUSVolition and VPG Launch Nu.Q® Vet Cancer Test in UK &..
06/11/202312:21PRNUSVolition and VPG Launch Nu.Q® Vet Cancer Test in UK &..
23/10/202314:00PRNUSVolition Presents Breakthrough Liquid Biopsy Blood Test..
20/10/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202322:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

AMEX
VNRX
VolitionRX
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés